The Market Size
Venture-capital funding of gene therapy assets ($ million)
Gene therapy market size ($ billion)
Competition
Technical Advantages
Developed an efficient method for constructing AdV vectors
Ability to develop AdV vectors for various strains and genetically manipulate their genomes
Develop hexon-chimeric AdV vectors to evade pre-existing/induced immunity
Develop fiber-modified AdV vectors to alter cellular tropism
Construct and try several configurations of episomal adenoviral plasmids for cell line development to produce gutless AdV vectors
Business Model
Products
Collaboration
Services
License-out
